AgboyiborKMGhamariS-HTyeSC, et al. First World Health Organization resolution on stroke at the seventy-ninth world health assembly: a turning point for global stroke prevention, care, and health-system readiness. Int J Stroke2026; 21: 735–741.
2.
NelsonMFredin GrupperMMVan der WorpH, et al. The importance of advocacy in advancing stroke care: the global stroke action coalition. Int J Stroke2026; 21: 584–590.
3.
SaadAKhanMEstolC, et al. Stroke and climate change: a World Stroke Organization scientific statement. Int J Stroke2026; 21: 742–758.
4.
RitsonMMarkusHSHarshfieldEL.Does illicit drug use increase stroke risk? A systematic review, meta-analyses, and Mendelian randomization analysis. Int J Stroke2026; 21: 788–800.
5.
BrownEDObeng-GyasiBJeongSW, et al. Is the association of cannabis use and stroke frequency-dependent: a cross-sectional analysis of the NIH all of us research program. Int J Stroke2026; 21: 815–826.
6.
Pantoja-RuizCLiuLLimE, et al. A systematic review of causal pathways of socioeconomic inequalities in stroke. Int J Stroke2026; 21: 801–814.
7.
FeiginVLBraininMNorrvingB, et al. World Stroke Organization: global stroke fact sheet 2025. Int J Stroke2025; 20: 132–144.
8.
StefanouM-IPanagiotopoulosELiberopoulosE, et al. Dyslipidemia management in stroke prevention: an individualized approach. Int J Stroke2026; 21: 759–777.
9.
Parry-JonesARKrishnamurthiRZiaiWC, et al. World Stroke Organization (WSO): global intracerebral hemorrhage factsheet 2025. Int J Stroke2025; 20: 145–150.
10.
PutriVPSamarasekeraNMoullaaliTJ, et al. Rates and risk factors for major adverse cardiovascular and cerebrovascular events after stroke due to intracerebral hemorrhage: systematic review and study-level meta-analysis. Int J Stroke2026; 21: 778–787.
11.
MarkusHS.Patent formen ovale closure, improving fitness after stroke, optimising hyperacute stroke treatment, and the Global Stroke Action Coalition. Int J Stroke2026; 21: 580–538.
12.
CampbellBCKasnerSEListaAD, et al. Safety and tolerability of Rinvecalinase Alfa (DM199) for acute ischemic stroke (ReMEDy1). Int J Stroke2026; 21: 861–870.
13.
PirlogBOJacobAPRajanSS, et al. Outcomes of patients with pre-existing disability managed by mobile stroke units: a sub-analysis of the BEST-MSU study. Int J Stroke2023; 18: 1209–1218.
14.
WuXLiJFuT, et al. A novel rendezvous approach between mobile stroke units and EMS improves timely thrombolysis in rural areas. Int J Stroke2026; 21: 839–849.
15.
EvansNRPinhoJBeishonL, et al. Frailty and stroke: global implications for assessment, research, and clinical care—a WSO scientific statement. Int J Stroke2025; 20: 905–917.
16.
WangCQianXZhaoXJinMJiaCJiaF.Frailty index changes before and after stroke: findings from four cohorts covering 18 countries. Int J Stroke2026; 21: 871–878.
